The control arm (C), and patients arm (AML) are shown in the boxplots, and the expression of all markers (CD61, CD41, CD42a, CD42b, CD62p, CD63) are decreased in AML patients comparing to controls. Here, CD63 is linked to acute myeloid leukemia.